SCHEMBL27103673

SCHEMBL27103673

C=CCC(C)(C)C(=O)OCn1c(=O)c2c(ccn2COC(=O)C(C)(C)CCC)n(CCOC(C)C)c1=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23218019 0.95 OPRM1 (0.32) —
SCHEMBL23225679 0.94 — —
SCHEMBL27144508 0.85 — —
SCHEMBL23217963 0.84 POLB (0.38) —
SCHEMBL23225706 0.79 POLB (0.34) —
SCHEMBL23225714 0.78 OPRM1 (0.48) —
SCHEMBL23225604 0.77 MPO (0.35) —
SCHEMBL23225722 0.75 OPRM1 (0.32) —
SCHEMBL27103572 0.75 OPRM1 (0.32) —
SCHEMBL27102076 0.74 KDM4E (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067651-A1 PRODRUGS OF MYELOPEROXIDASE INHIBITORS BIOHAVEN THERAPEUTICS LTD. 2024-02-29 — — US disclosed
Send feedback